Operam ad mane protegendo de GBS

I Quid est GBS?

Group B Streptococcus (GBS) est gram, positivum Streptococcus, quod est in inferioribus digestive tractus et genitourinary tractus humani corporis. Est opportunistic morbis maxime inficit uteri et foetus membranas per ascendentem naturale. GBS potest causare materno urinariorum tractu infectio, intrauterine infectio, Bacteremia et postpartum endometritis et auget periculo premature partus et stillbirth.

GBS potest etiam ducere neonatales vel infans infectio. De X% -30% of gravida mulieres pati ex gls infectio. L% horum potest esse traducitur directe ad natum per partum sine interventu, unde in neonatal infectio.

According to the onset time of GBS infection, it can be divided into two types, one is GBS early-onset disease (GBS-EOD) ,which occurs 7 days after delivery, mainly occurs 12-48 hours after delivery, and mainly manifests as Neonatal Bacteremia, Pneumonia, aut Meningitis. Et alius est GBS nuper-impetu morbus (GBS, LOD), quod fit ab VII diebus ad III menses postpartum et manifestat maxime ut neonatal / infans Bacteremia, Meningitis infectio.

Prenatal GBs protegendo et intrapragratum antibiotic interventu potest efficaciter reducere numerum neonatal mane-impetu infectiones, auget neonatal salvos rate et qualis vitae.

II Quam ne?

In MMX, in US Centrorum pro Morbus Control et praeventionis (CDC) formata est "Guidelines ad praeventionis perinatal GBS", commendat exercitatione protegendo ad GBS ad 35-37 septimanas in tertio trimester ad.

In MMXX, in American College of Obstetricians et Gynecologists (Acog) "Consensus in praeventionis in mane-impetu Group B Streptococcal Morbus in Newbring inter XXXVI + 0-37 + weeks in graviditate.

In MMXXI, in "Periti Consensu in praeventionis perinatalis Group B Streptococcal Morbus (Sina)" issued by perinatal medicamina de Seres Medical Medical ad 35-37 septimanas. Hoc suadet quod GBS protegendo valet pro V weeks. Et si gbs negans hominem non tradidit pro magis quam V hebdomades, commendatur ut repetere protegendo.

III solution

Macro & Micro-test est developed Group B Streptococcus nucleiic acidum deprehendatur Kit (Fluorescence PCR), quod deprehendit exemplaria ut aestimare statum in gbs infectio et diagnosis, et adiuvaret gravida mulieres in gbs infectio diagnosis. Quod productum est certified per EU et US FDA et habet optimum productum perficientur et bonum user usus.

Img_4406 Img_4408

Commoda

Celeri: Simple sampling, unus-step extraction, celeri deprehensio

High sensibility: et Lod de ornamentum est M copies / ml

Multi, Subtype, inter XII Subtypes ut La, LB, LC, II, III

Anti-pollutio: UNZME additur ad systema ad effective ne nucleic acidum pollutio in Laboratory

 

Catalogus Number Product Name Specificatio
HWTS, Ur027a Group B Streptococcus nucleic acidum deprehensio Kit (Fluorescence PCR) L probat / ornamentum
HWTS, Ur028a / B Frigidus-siccatur Group B Streptococcus nucleic Acidum deprehendatur Kit (Fluorence PCR) XX probat / ornamentumL probat / ornamentum

Post tempus: Dec-15-2022